Description

The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report instrument designed to assess the presence and severity of symptoms associated with Post-Traumatic Stress Disorder (PTSD) according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

The PCL-5 was developed by the U.S. Department of Veterans Affairs’ National Center for PTSD as an updated version of earlier PTSD Checklist instruments following revisions to the diagnostic criteria for PTSD in DSM-5.

Each of its 20 items corresponds to a DSM-5 PTSD symptom. The instrument can be used to quantify overall PTSD symptom severity, support screening for probable PTSD, and monitor changes in symptoms over time.

Symptom Clusters

The 20 PCL-5 items correspond to the four DSM-5 PTSD symptom clusters:

Intrusion: Includes recurrent and distressing memories, nightmares, flashbacks, and psychological or physiological reactions to reminders of the traumatic event.

Avoidance: Includes efforts to avoid distressing memories, thoughts, feelings, people, places, conversations, activities, or situations associated with the traumatic experience.

Negative Alterations in Cognitions and Mood: Includes persistent negative beliefs or emotional states, diminished interest in activities, feelings of detachment, difficulties experiencing positive emotions, and other trauma-related cognitive and emotional changes.

Alterations in Arousal and Reactivity: Includes irritability, hypervigilance, exaggerated startle responses, concentration difficulties, sleep disturbance, and other changes in physiological or behavioral reactivity.

This structure enables researchers and clinicians to examine both overall symptom severity and patterns across the major DSM-5 PTSD symptom domains.

Purpose

The primary purpose of the PCL-5 is to provide a standardized method for the quantitative assessment of PTSD symptom severity.

The instrument may be used to:

assess the severity of PTSD symptoms,

screen for probable PTSD,

monitor symptom changes during or following treatment,

evaluate changes over repeated assessments,

and investigate PTSD symptoms in clinical, epidemiological, and research populations.

The PCL-5 can therefore provide useful information both for initial assessment and for longitudinal monitoring.

Administration

Respondents indicate how much they have been bothered by each of the 20 PTSD symptoms during the specified reference period.

Each item is rated using a 5-point Likert-type scale ranging from 0 to 4, where higher values indicate greater symptom-related distress.

The instrument can be administered in different formats depending on the assessment purpose and the manner in which the traumatic event is identified.

Consistent administration procedures and an appropriate reference period are important when scores are compared across individuals or over time.

Scoring

The total PCL-5 score is calculated by summing the responses to all 20 items.

The total score ranges from:

0 to 80

with higher scores indicating greater overall PTSD symptom severity.

In addition to the total score, symptom-cluster scores may be calculated by summing the items corresponding to each of the four DSM-5 PTSD symptom clusters.

The total score is particularly useful as a continuous measure of PTSD symptom severity, especially in research and treatment-monitoring applications.

Cut-Off Scores and Interpretation

Various cut-off scores have been investigated for identifying individuals with probable PTSD. A total score around 31–33 has frequently been considered useful in some populations and assessment contexts, and a score of 33 is commonly referenced as a possible screening threshold.

However, a single universal cut-off should not be assumed to be optimal for every population.

The appropriate threshold may vary according to factors such as population characteristics, trauma exposure, clinical setting, prevalence of PTSD, and the intended balance between sensitivity and specificity.

Consequently, cut-off scores should be selected according to the specific purpose and population of the assessment and supported by relevant validation evidence whenever possible.

Reliability and Validity

The PCL-5 has demonstrated strong psychometric properties across numerous research and clinical applications.

Initial validation research reported high internal consistency and evidence supporting convergent and discriminant validity. Subsequent studies have provided additional support for its reliability and validity across different populations, including treatment-seeking individuals and military populations.

The factorial structure of the PCL-5 has also been extensively investigated. When the instrument is translated, culturally adapted, or applied to a substantially different population, evaluation of its reliability, validity, and measurement structure within that population is recommended.

Data Analysis

PCL-5 scores can be analyzed as continuous measures of PTSD symptom severity. Descriptive analyses may include means, standard deviations, medians, ranges, and score distributions.

Internal consistency can be evaluated using appropriate reliability coefficients. Relationships between PTSD symptom severity and other psychological, demographic, clinical, or social variables can be examined using correlation and regression analyses.

Group differences may be investigated using appropriate parametric or non-parametric statistical procedures.

In psychometric studies, confirmatory factor analysis (CFA) may be used to examine the underlying symptom structure.

When the objective is to evaluate the screening performance of a proposed cut-off score, receiver operating characteristic (ROC) analysis can be used to estimate sensitivity, specificity, and the area under the ROC curve (AUC).

Longitudinal and repeated-measures methods may also be applied when assessing symptom changes over time or following an intervention.

Clinical and Research Applications

The PCL-5 is widely applicable in clinical research, epidemiological studies, trauma research, treatment evaluation, and longitudinal assessment.

It can contribute to identifying individuals who may require more comprehensive assessment, quantifying the burden of PTSD symptoms, examining relationships between traumatic experiences and psychological outcomes, and monitoring symptom trajectories.

In intervention research, repeated administration can provide information about changes in symptom severity and contribute to evaluating treatment outcomes.

Important Considerations

The PCL-5 is a self-report measure and should not be considered a standalone diagnostic instrument.

A high total score or a score exceeding a proposed screening threshold may indicate clinically important PTSD symptoms or probable PTSD, but it does not independently establish a definitive diagnosis.

Formal diagnosis requires appropriate clinical assessment and consideration of the full diagnostic criteria, including trauma exposure, symptom duration, functional impairment, exclusionary considerations, and other relevant clinical information.

Therefore, PCL-5 results should be interpreted within the broader clinical and research context in which the instrument is administered.

References

Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). National Center for PTSD; 2013.

Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. Journal of Traumatic Stress. 2015;28(6):489–498.

Wortmann JH, Jordan AH, Weathers FW, Resick PA, Dondanville KA, Hall-Clark B, et al. Psychometric analysis of the PTSD Checklist-5 (PCL-5) among treatment-seeking military service members. Psychological Assessment. 2016;28(11):1392–1403.